Department of Dermatology, University of California San Diego, San Diego, California, USA.
Department of Pathology, East Carolina University, Greenville, North Carolina, USA.
J Cutan Pathol. 2022 Oct;49(10):898-916. doi: 10.1111/cup.14264. Epub 2022 Aug 4.
Cutaneous lymphoid hyperplasia (CLH), also known as cutaneous pseudolymphoma, is a spectrum of benign conditions characterized by reactive B- and T-cell cutaneous lymphocytic infiltrates. B-cell lymphoid proliferations are a heterogenous group of non-neoplastic cutaneous diseases that must be histopathologically distinguished from cutaneous B-cell lymphomas. These proliferations can be observed as reactive phenomena to infections, medications, allergens, neoplasms, and more. Furthermore, there are many inflammatory conditions that present with reactive B-cell infiltrates, including actinic prurigo, Zoon balanitis, Rosai-Dorfman disease, and cutaneous plasmacytosis. This review summarizes multiple cutaneous B-cell lymphoid proliferations within the major categories of reactive and disease-associated CLH. Further we discuss major discriminating features of atypical CLH and malignancy. Understanding the specific patterns of B-cell CLH is essential for the proper diagnosis and treatment of patients presenting with such lesions.
皮肤淋巴组织增生症(CLH),也称皮肤假性淋巴瘤,是一组以反应性 B 细胞和 T 细胞皮肤淋巴细胞浸润为特征的良性疾病谱。B 细胞淋巴组织增生是一组非肿瘤性皮肤疾病,必须通过组织病理学与皮肤 B 细胞淋巴瘤区分。这些增生可能是对感染、药物、过敏原、肿瘤等的反应性表现。此外,还有许多炎症性疾病表现为反应性 B 细胞浸润,包括光化性痒疹、动物园肉芽肿性睾丸炎、罗斯氏-多夫曼病和皮肤浆细胞瘤。本文总结了主要的反应性和与疾病相关的 CLH 中多种皮肤 B 细胞淋巴组织增生。此外,我们还讨论了非典型 CLH 和恶性肿瘤的主要鉴别特征。了解 B 细胞 CLH 的特定模式对于正确诊断和治疗出现此类病变的患者至关重要。